Understanding how hepatitis E virus leaves liver cells
Mechanism for hepatitis E virus exit from polarized hepatocytes
This study is looking at how the hepatitis E virus leaves liver cells, focusing on a specific protein that helps with this process, to find better ways to prevent and treat hepatitis E, especially for people with weakened immune systems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11012885 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the hepatitis E virus (HEV) exits polarized liver cells, which is crucial for understanding its infectious cycle. The study focuses on the role of a specific viral protein, ORF3, and its interaction with cellular machinery that facilitates the virus's release. By using human liver cell cultures and animal models, the research aims to uncover the complexities of HEV release, which could lead to new prevention and treatment strategies for hepatitis E. The findings could provide insights into the virus's behavior in immunocompromised individuals, who are at higher risk of severe disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of hepatitis E infection, particularly those who are immunocompromised.
Not a fit: Patients who have already been diagnosed with chronic hepatitis E or those without risk factors for infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective prevention and treatment options for hepatitis E, addressing a significant public health concern.
How similar studies have performed: Previous research has shown promise in understanding viral mechanisms in other infections, suggesting that this approach could yield valuable insights, although the specific focus on HEV is relatively novel.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Feng, Zongdi — Research Inst Nationwide Children's Hosp
- Study coordinator: Feng, Zongdi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.